// App-Quantinova.ai

e18128 : Feasibility of a high-throughput molecular tumor board (MTB) to provide clinical practice guidance following comprehensive molecular profiling (CMP).

Researchers

Presenter

  • Ari M. Vanderwalde

Principal Investigators

  • Gy Won Choi

  • Gregory A. Vidal

  • Jason Claud Chandler

  • Bradley G. Somer

  • Lee Steven Schwartzberg

Medical Centers

  • West Cancer Center, Memphis, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Tamsulosin Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved